Sort
23,748 grants matching “melanoma”
MECHANISMS OF IL-2 IMMUNE ENHANCEMENT IN HUMANS
$273,363Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · AI
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$273,356Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
The PINK1 Mitochondrial Signaling Pathway
$273,352Lian Li · Emory University · R01 · FY2009 · GM
Radiation Biology of EPR Oxygen Images
$273,274Howard J Halpern · University Of Chicago · R01 · FY2009 · CA
Nanostructured Cancer Vaccines
$273,231T. Andrew Taton · University Of Minnesota · R01 · FY2008 · CA
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting
$273,199Frank Markus · Brigham And Women'S Hospital · P50 · FY2010 · CA
Structural basis for RIG-I and MDA-5 mediated antiviral response
$273,158Karl-Peter Hopfner · University Of Southern California · U19 · FY2011 · AI
Flow Cytometry Shared Resource (FCSR)
$273,136Zoran Galic · University Of California Los Angeles · P30 · FY2020 · CA
Cell intrinsic and extrinsic effects of zinc metabolism in therapy resistant melanoma
$273,065Katherine Marie Aird · Wistar Institute · R01 · FY2025 · CA
Targeted Drug Delivery to Surface Receptors
$273,014Francis C Szoka · University Of California, San Francisco · R01 · FY2009 · GM
Biology Core
$272,984Meenhard Herlyn · Wistar Institute · P01 · FY2023 · CA
Mimimal-Perturbation Dynamic Control of the Melanoma Gene Regulatory Network
$272,881Dan Schonfeld · University Of Illinois At Chicago · R01 · FY2013 · GM
Pathways governing survival of neural crest derivatives
$272,875University Of Iowa · R01 · FY2005 · GM
Epigenetic regulation of cancer/germ-line antigen gene expression
$272,863Adam R Karpf · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA
Core 1: Biospecimen and Translational Pathology Core
$272,776Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA
IDENTIFICATION OF CD8+ T CELL TARGETS ON RENAL CANCER
$272,743Johns Hopkins University · R01 · FY2002 · CA
Role of IKK in NSCLC Modulation of SMRT and NF-kappab
$272,700Marty W Mayo · University Of Virginia · R01 · FY2006 · CA
DENDRITIC CELL BASED GENETIC IMMUNOTHERAPY FOR MELANOMA
$272,671University Of California Los Angeles · R01 · FY2001 · CA
Targeted Drug Delivery to Surface Receptors
$272,664Francis C Szoka · University Of California, San Francisco · R01 · FY2008 · GM
Role of DeltaNp63alpha in Vitamin D Mediated Cell Survival in Skin Cancer
$272,655Madhavi P Kadakia · Wright State University · R01 · FY2015 · CA
Role of DeltaNp63alpha in Vitamin D Mediated Cell Survival in Skin Cancer
$272,655Madhavi P Kadakia · Wright State University · R01 · FY2016 · CA
Regulation of Cytokine Gene Expression by mRNA Turnover
$272,602Sidney Pestka · Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2006 · AI
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$272,582Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
ANALYSIS OF CD8 T CELL RESPONSES TO TUMORS
$272,475Trudeau Institute, Inc. · R01 · FY2002 · CA
ANALYSIS OF CD8 T CELL RESPONSES TO TUMORS
$272,475Trudeau Institute, Inc. · R01 · FY2001 · CA